Skip to main content
Caplight Logo









Pleno Inc

Pleno Inc

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://plenoinc.com/

Last Round

Series B

Dec 12, 2024

Total Funding Raised

$80M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Pleno Inc is a biotechnology company that develops a multi-omic instrument platform for biological target detection, facilitating clinical testing and biomedical research through rapid and precise monitoring of various biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Application

Keywords

multi-omicsbiological analysisgenomic studieslab automationhigh-throughput screeningbiotech instrumentationprecision medicinelife science toolsreagentsbio-techbenchtop sequencerconsumablesdata-as-a-service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pleno Inc Comparables

Compare Pleno Inc with similar companies based on industry and business-model similarity.

Pleno Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Singular Genomics
82%
Mission Bio
79%
Spatial Genomics
78%

Pleno Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 12, 2024
Series AOct 12, 2022
Pre SeedMay 18, 2022

Key People

Founding team and executive leadership

Vik Vaz

Chief Executive Officer President

Executive Team

Pleno Inc Investors

Notable investors and investment history

Pleno Inc investors
InvestorRounds
Deerfield ManagementSeries A, Series B
Medical Excellence CapitalSeries B, Pre Seed
EvoNexusPre Seed
Foresite CapitalSeries A, Series B
Alexandria Venture InvestmentsPre Seed
Alexandria Venture InvestmentsPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 30% MoM, reaching 3.9K.

  • Mar 30, 2026

    RAPTOR platform has launched or is launching.

Pleno Inc Filings

Explore SEC and related filing metadata, where available.

Pleno Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pleno Inc's valuation, stock price, and market status.

Is Pleno a public or private company?

Pleno is a private company.

What is the current stock price of Pleno?

Pleno is a private company with no public stock price. No recent secondary market data is available.

How much is Pleno worth (valuation)?

Valuation information for Pleno is not publicly available.

Can I buy Pleno stock?

Pleno shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pleno's last funding round?

Pleno's most recent funding round was Series B on December 12, 2024.

Who are the main investors in Pleno?

Key investors in Pleno include Deerfield Management, Medical Excellence Capital, Alexandria Venture Investments.

Will Pleno IPO soon?

No public IPO plans have been announced for Pleno.

How can I track Pleno secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pleno's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range29
Year Founded2021
Last FundingDec 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?